Citation Impact
Citing Papers
Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer
2015
Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer
2016
Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma
2016
Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma
2015
Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression
2021 StandoutNobel
Establishment and characterization of a novel murine model of pancreatic cancer cachexia
2017
Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-mediated mechanism
2021
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
2019
Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus Entry
2015 StandoutNobel
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention
2016
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Ancient Origin of cGAS-STING Reveals Mechanism of Universal 2′,3′ cGAMP Signaling
2015 StandoutNobel
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Whole-Cell Cancer Vaccines Induce Large Antibody Responses to Carbohydrates and Glycoproteins
2016
Pancreatic cancer
2020 Standout
Tertiary lymphoid structures in cancer and beyond
2014
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Pancreatic cancer
2016 Standout
SCENIC: single-cell regulatory network inference and clustering
2017 Standout
Activation of IGF/IGF-IR signaling pathway fails to induce epithelial-mesenchymal transition in pancreatic cancer cells
2019
Hepatocellular carcinoma
2021 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Tertiary Lymphoid Tissue in the Tumor Microenvironment: From Its Occurrence to Immunotherapeutic Implications
2015
PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
2014
The tumor microenvironment
2020 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Cancer-associated cachexia
2018 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas
2015
Tertiary lymphoid structures in the era of cancer immunotherapy
2019
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
Targeting neoantigens to augment antitumour immunity
2017
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Emerging Biological Principles of Metastasis
2017 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility
2016
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Reassessment of Exosome Composition
2019 Standout
Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression
2021 StandoutNobel
Fibroblasts as immune regulators in infection, inflammation and cancer
2021
Tumor Immunology and Tumor Evolution: Intertwined Histories
2020
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
2016 Standout
Renal cell carcinoma
2017 Standout
CD40 Stimulation Obviates Innate Sensors and Drives T Cell Immunity in Cancer
2016
B cells, plasma cells and antibody repertoires in the tumour microenvironment
2020
Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC)
2015
STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
2019
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities
2022
STAT3 in cancer: A double edged sword
2017
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Annexin A2 and S100A10 Regulate Human Papillomavirus Type 16 Entry and Intracellular Trafficking in Human Keratinocytes
2013
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Tertiary lymphoid structures, drivers of the anti‐tumor responses in human cancers
2016
Diversity and Biology of Cancer-Associated Fibroblasts
2020
The Lymphatic System: Integral Roles in Immunity
2016 Standout
Strategies in Developing Immunotherapy for Pancreatic Cancer: Recognizing and Correcting Multiple Immune “Defects” in the Tumor Microenvironment
2019
Irreversible electroporation of locally advanced pancreatic cancer transiently alleviates immune suppression and creates a window for antitumor T cell activation
2019
Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma
2015
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer
2022 StandoutNobel
STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
2015
Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors
2013
Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity
2015
Genetics and biology of pancreatic ductal adenocarcinoma
2016
TGF-β blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent manner
2015
Works of Guanglan Mo being referenced
Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic Cancer
2016
Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
2014
Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation
2016
Tyrosine 23 Phosphorylation-Dependent Cell-Surface Localization of Annexin A2 Is Required for Invasion and Metastases of Pancreatic Cancer
2011
Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer
2015